These results suggest that inhibition of cardiac fibroblast proliferation may also contribute to ameliorated cardiac remodeling and reduced cardiac hypertrophy in Ang II–treated IKKβΔFib mice. The gene discussed is AGT; the disease is cardiac hypertrophy.